LSBio
IHC-plus™ CD39 Antibody (aa38-307, clone 2B10)

Human Placenta: Formalin-Fixed, Paraffin-Embedded (FFPE)

IHC-plus™ CD39 Antibody (aa38-307, clone 2B10)

Primary AntibodyLSBio Guarantee
Antibody:Mouse Monoclonal
Applications:Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot
Reactivity:Human
Format:Liquid
See all CD39 antibodies →
$470.00each
Catalog Number: LS-B13080-50

For bulk orders or custom formulations:

Request a Quote

Overview

Description
CD39 antibody LS-B13080 is an unconjugated mouse monoclonal antibody to human CD39 (aa38-307). Validated for IHC and WB. Tested on 20 paraffin-embedded human tissues. Cited in 1 publication.
Application
IHC, IHC-P, WB
Reactivity
Hu
Intended Use
Research Use Only
Guarantees
This product carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Monoclonal Antibodies
Alternative Names
ATPDase | CD39 | CD39 antigen | Ecto-apyrase | Ecto-ATPDase 1 | Ecto-ATP diphosphohydrolase 1 | Ecto-ATPase 1 | NTPDase-1 | ENTPD1 | NTPDase 1
Recommended Dilution: IHC-P
10 µg/ml
Recommended Dilution: WB
1:2000
UniProt Number
P49961
SwissProt
P49961

Target

Target
CD39
Antigen Species
Human
Specificity
aa38-307 of human CD39
Epitope
Human CD39
Gene Name
ENTPD1

Antibody

Host Species
Mouse
Clonality
Monoclonal
Clone
2B10
Origin Species
Human

Immunogen

Immunogen
Human recombinant protein fragment corresponding to amino acids 38-307 of human ENTPD1 (NP_001767) produced in E. coli.
Immunogen Type
Recombinant Protein Fragment

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS, pH 7.3, 0.02% Sodium Azide, 50% Glycerol, 1% BSA
Concentration
1 mg/mL
Volume
50 Microliter
Animal Free
No
Carrier-Free
No
Preservative
Yes
Purification Method
Affinity Purified

Storage & Handling

Storage Conditions
Store at -20°C for up to 1 year. Avoid freeze-thaw cycles.
Recommended Storage Buffer
PBS
Immune related endonucleases and GTPases are not associated with tumor response in patients with advanced non-small cell lung cancer treated with checkpoint inhibitors. H O Ramdani, M Falk, L C Heukamp, S Schatz, M Tiemann, C Wesseler, L Diehl, E Schuuring, H J M Groen, F Griesinger. Pathology, research and practice. 2021 November;227:153651. PubMed: 34673351

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.